China's LEAPER RNA Editing Platform Achieves First Clinical Milestone in Duchenne Muscular Dystrophy | Answer

China's LEAPER RNA Editing Platform Achieves First Clinical Milestone in Duchenne Muscular Dystrophy | Answer | Studio Global AI